Clinical Diagnostics & Theranostics

Our Advanced Diagnostic Scans & Targeted Therapies

From ultra-precise molecular PET-CT imaging and dynamic nuclear Gamma Camera studies to targeted radionuclide therapy and comprehensive cancer screening in Karimnagar.

Whole body Pet ct scan PSMA PET CT DOTA PET CT DTPA renogram Thyroid scan Bone scan Cancer screening RAI therapy LU dota therapy LU PSMA Therapy

PET-CT Imaging

Advanced Molecular PET-CT Scans

Oncology Gold Standard

Whole Body PET-CT Scan

High-resolution molecular metabolic scan utilizing F-18 Fluorodeoxyglucose (FDG) to map hyper-metabolic neoplastic lesions from skull to mid-thigh.

Early localization of primary tumors & silent metastases
Accurate TNM staging & precise radiation field planning
Early evaluation of chemotherapy & immunotherapy response
Differentiating post-treatment scar tissue from recurrence

Book PET-CT Scan

Prostate Oncology

PSMA PET CT

Gallium-68 (Ga-68) PSMA targeted imaging with ultra-high affinity for Prostate-Specific Membrane Antigen expressed by prostate adenocarcinoma cells.

Definitive primary staging of high-risk prostate cancer
Detects recurrence at ultra-low PSA levels (< 0.2 ng/mL)
Superior sensitivity for lymph node & bone micrometastases
Theranostic screening for Lu-177 PSMA radioligand therapy

Book PSMA PET-CT

NET Diagnostics

DOTA PET CT

Ga-68 DOTATATE / DOTANOC imaging targeting somatostatin receptors (SSTR-2 & SSTR-5) on Neuroendocrine Tumors (NETs) and carcinoids.

Precise localization of occult carcinoids & pancreatic NETs
High-contrast mapping of mesenteric & hepatic metastases
Essential screening to confirm PRRT (Lu-177 DOTA) candidacy
Post-surgical surveillance and treatment response monitoring

Book DOTA PET-CT

Gamma Camera

Nuclear Medicine & Dynamic Functional Scans

Renal Dynamic

DTPA Renogram

Dynamic scintigraphic study evaluating renal blood flow, glomerular filtration rate (GFR), individual split kidney function, and urinary clearance kinetics.

Accurate quantitative split renal function percentage (L vs R)
Glomerular Filtration Rate (GFR) measurement
Differentiates pelvi-ureteric (PUJ) obstruction via Lasix protocol
Pre-operative donor and nephrectomy clearance evaluation

Book DTPA Renogram

Endocrine Diagnostics

Thyroid Scan

Functional thyroid imaging using Tc-99m Pertechnetate / I-131 to assess glandular trapping, functional thyroid anatomy, and nodule characterization.

Evaluates toxic goiter, Graves' disease & thyrotoxicosis
Differentiates functioning "hot" vs non-functioning "cold" nodules
Identifies retrosternal, lingual, and ectopic thyroid tissue
Guides dosage calculation for Radioactive Iodine (RAI) therapy

Book Thyroid Scan

Skeletal Scintigraphy

Bone Scan (Whole Body)

Whole-body skeletal scintigraphy using Tc-99m MDP to detect osteoblastic activity, bone remodeling, and skeletal metastases months before visible on X-rays.

Early screening for bone metastases from breast, prostate & lung
Diagnoses occult stress fractures, sports injuries & trauma
Assesses suspected osteomyelitis, prosthetic loosening & arthritis
Comprehensive full-skeleton assessment in a single procedure

Book Bone Scan

Theranostics

Targeted Radionuclide Therapies (Theranostics)

Thyroid Ablation

RAI Therapy (I-131)

Radioactive Iodine (I-131) targeted oral therapy providing curative ablation for hyperthyroidism and adjuvant remnant ablation for differentiated thyroid cancer.

Curative treatment for Graves' disease & toxic multi-nodular goiters
Post-thyroidectomy ablation of residual microscopic thyroid tissue
Targeted therapy for metastatic papillary & follicular thyroid cancer
Administered under stringent BARC & AERB radiation safety protocols

Consult RAI Therapy

PRRT for NETs

LU DOTA Therapy

Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) delivering targeted cytotoxic beta-radiation directly into somatostatin receptor-positive neuroendocrine tumor cells.

Proven efficacy for progressive, unresectable or metastatic NETs
Significant symptom relief from carcinoid syndrome & tumor reduction
Substantial improvement in progression-free and overall survival
Guided by pre-treatment Ga-68 DOTA PET-CT with post-therapy dosimetry

Consult LU DOTA PRRT

Targeted Radioligand

LU PSMA Therapy

Breakthrough Lutetium-177 PSMA radioligand theranostics for advanced, metastatic castration-resistant prostate cancer (mCRPC), destroying cancer cells wherever they have spread.

Targeted treatment for advanced prostate cancer resistant to hormone therapy
Documented significant PSA reduction & tumor regression
Alleviates severe bone pain, enhancing functional quality of life
Personalized patient eligibility determined via Ga-68 PSMA PET-CT

Consult LU PSMA Therapy

Preventive Care

Early Detection & Preventive Oncology

Preventive Oncology

Comprehensive Cancer Screening

Early cancer detection saves lives. IRIS PET-CT Centre provides advanced diagnostic screening packages designed to detect pre-cancerous abnormalities and occult, asymptomatic tumors at their earliest and most treatable stages.

High-risk hereditary & family history profiling

Whole-body metabolic & anatomical screening

Multi-organ malignancy detection panels

Direct review by BARC-trained nuclear physicians

Book Screening Package

Schedule your preventive screening consultation with our specialist oncological imaging team.

Schedule Screening Inquire on WhatsApp

Specialized Scans

Additional Specialized Molecular Imaging

Ga-68 FAPI PET-CT

Targets fibroblast activation protein in tumor stroma, offering exceptional sensitivity for low-FDG-avid cancers (pancreatic, gastric, breast, peritoneal carcinomatosis).

Book FAPI Scan

Brain Metabolic PET-CT

High-resolution regional cerebral glucose metabolism mapping to differentiate Alzheimer's, FTD, Lewy Body dementia, and locate refractory epileptogenic foci.

Book Brain Scan

Cardiac Viability PET

Assesses myocardial perfusion and metabolic viability post-myocardial infarction to identify hibernating myocardium that benefits from revascularization.

Book Cardiac Scan

Scans & Therapies